<qa>  What is the purpose of this study?The purpose of this study is to evaluate the 24-hour spirometry effect FEV1 of FFVI 10025mcg once daily compared with Fluticasone PropionateSalmeterol 25050mcg twice daily over a 12-week treatment period in subjects with COPD. 